Pituitary Apoplexy Precipitated by Non-Cranial Surgeries: An Institutional Experience

Abstract

Introduction

Pituitary apoplexy (PA) is a rare, acute condition caused by hemorrhage or infarction within the pituitary gland, primarily associated with preexisting adenomas. Classically, PA presents with severe headache, neuro-ophthalmologic deficits, and/or endocrine disturbances. While the mechanisms of PA are under investigation, vascular changes, blood flow disruptions, and intrasellar pressure are implicated. We report the first 6-year institutional experience of risk factors of PA associated with non-cranial surgeries.

Methods

A retrospective review was conducted of patients presenting with PA from July 2017 to January 2024. Patients diagnosed with PA within 1 week of non-cranial surgery were included. Data encompassed medical history, surgical details, presenting symptoms, imaging, and outcomes.

Results

Among 56 PA patients, 4 (7.1%) occurred after non-cranial surgeries, including cardiac procedures, mandibulectomy, and toe amputation. Three male patients (one excluded due to incomplete data) presented with oculomotor deficits and endocrine dysfunction. All had lesions greater than 2 cm. Common risk factors included hypertension, significant intraoperative blood pressure fluctuations (systolic range: 60–200 mm Hg), and lengthy anesthesia (average: 9.09 hours). Symptom onset occurred within 24 hours postsurgery.

Conclusion

Despite differences in surgical context, several factors seemed to predispose these patients to PA: wide fluctuations in intraoperative blood pressure, preexisting hypertension, and macroadenomas exceeding 2 cm. In patients with known macroadenomas, risk stratification may be helpful based on adenoma size and comorbid conditions affecting vascular health. Sudden intraoperative changes in blood pressure should be avoided. For those with predisposing risk factors undergoing high-risk surgeries, especially cardiac procedures that utilize anticoagulation, obtaining a preoperative computed tomography (CT) head may be warranted.

Keywords

pituitary - apoplexy - non-cranial surgery

Ethical Approval

The authors confirm that all patient data used were anonymized and handled in compliance with institutional and ethical guidelines.

Authors' Contributions

All authors have reviewed the manuscript and approved its content for submission.

Publication History

Received: 08 January 2025

Accepted: 12 May 2025

Accepted Manuscript online:
14 May 2025

Article published online:
30 May 2025

• References

• 1 Glezer A, Bronstein MD. Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 2015; 59 (03) 259-264
• 2 Pyrgelis ES, Mavridis I, Meliou M. Presenting symptoms of pituitary apoplexy. J Neurol Surg A Cent Eur Neurosurg 2018; 79 (01) 52-59
• 3 Turgut M, Özsunar Y, Başak S, Güney E, Kir E, Meteoğlu I. Pituitary apoplexy: an overview of 186 cases published during the last century. Acta Neurochir (Wien) 2010; 152 (05) 749-761
• 4 Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary apoplexy. Endocr Rev 2015; 36 (06) 622-645
• 5 Donegan D, Erickson D. Revisiting pituitary apoplexy. J Endocr Soc 2022; 6 (09) bvac113
• 6 Johnston PC, Hamrahian AH, Weil RJ, Kennedy L. Pituitary tumor apoplexy. J Clin Neurosci 2015; 22 (06) 939-944
• 7 Barkhoudarian G, Kelly DF. Pituitary apoplexy. Neurosurg Clin N Am 2019; 30 (04) 457-463
• 8 Mou C, Han T, Zhao H, Wang S, Qu Y. Clinical features and immunohistochemical changes of pituitary apoplexy. J Clin Neurosci 2009; 16 (01) 64-68
• 9 Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JAH. Classical pituitary apoplexy: Clinical features, management and outcome. Clin Endocrinol (Oxf) 1999; 51 (02) 181-188
• 10 Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: Characteristics, treatment, and outcomes. Neurosurg Focus 2004; 16 (04) E6
• 11 Boellis A, di Napoli A, Romano A, Bozzao A. Pituitary apoplexy: An update on clinical and imaging features. Insights Imaging 2014; 5 (06) 753-762
• 12 Almeida JP, Sanchez MM, Karekezi C. et al. Pituitary apoplexy: Results of surgical and conservative management clinical series and review of the literature. World Neurosurg 2019; 130: e988-e999
• 13 Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJL. Acute management of pituitary apoplexy–surgery or conservative management?. Clin Endocrinol (Oxf) 2004; 61 (06) 747-752
• 14 Rajasekaran S, Vanderpump M, Baldeweg S. et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 2011; 74 (01) 9-20
• 15 Sibal L, Ball SG, Connolly V. et al. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 2004; 7 (03) 157-163
• 16 Singh TD, Valizadeh N, Meyer FB, Atkinson JLD, Erickson D, Rabinstein AA. Management and outcomes of pituitary apoplexy. J Neurosurg 2015; 122 (06) 1450-1457
• 17 Bi WL, Dunn IF, Laws Jr ER. Pituitary apoplexy. Endocrine 2015; 48 (01) 69-75
• 18 Rolih CA, Ober KP. Pituitary apoplexy. Endocrinol Metab Clin North Am 1993; 22 (02) 291-302
• 19 Rovit RL, Fein JM. Pituitary apoplexy: A review and reappraisal. J Neurosurg 1972; 37 (03) 280-288
• 20 Cardoso ER, Peterson EW. Pituitary apoplexy: A review. Neurosurgery 1984; 14 (03) 363-373
• 21 Di Ieva A, Weckman A, Di Michele J. et al. Microvascular morphometrics of the hypophysis and pituitary tumors: from bench to operating theatre. Microvasc Res 2013; 89: 7-14
• 22 Nawar RN, AbdelMannan D, Selman WR, Arafah BM. Pituitary tumor apoplexy: A review. J Intensive Care Med 2008; 23 (02) 75-90
• 23 Ranabir S, Baruah MP. Pituitary apoplexy. Indian J Endocrinol Metab 2011; 15 Suppl 3 (Suppl. 03) S188-S196
• 24 Mayrin JV, Laufgraben M. Pituitary apoplexy following cardiac surgery: A case report and review of the literature. Endocrinologist 2007; 17 (04) 214-216
• 25 Yakupoglu H, Onal MB, Civelek E, Kircelli A, Celasun B. Pituitary apoplexy after cardiac surgery in a patient with subclinical pituitary adenoma: Case report with review of literature. Neurol Neurochir Pol 2010; 44 (05) 520-525
• 26 Li Y, Qian Y, Qiao Y. et al. Risk factors for the incidence of apoplexy in pituitary adenoma: A single-center study from southwestern China. Chin Neurosurg J 2020; 6: 20